During the past decade, Agencia Costarricense de Investigaciones Biomédicas (ACIB) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Agencia Costarricense de Investigaciones Biomédicas (ACIB)" #1 collaborator was "Bill and Melinda Gates Foundation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Agencia Costarricense de Investigaciones Biomédicas (ACIB)" are "Human Papillomavirus Infection" (3 trials), "Human Papillomavirus-Related Cervical Carcinoma" (3 trials), "Anal Carcinoma" (1 trials), "Cervical Carcinoma" (1 trials) and "Human Papillomavirus-Related Malignant Neoplasm" (1 trials). Many other conditions were trialed in "Agencia Costarricense de Investigaciones Biomédicas (ACIB)" in a lesser frequency.

Most popular intervention types in "Agencia Costarricense de Investigaciones Biomédicas (ACIB)" are "Other" (3 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Questionnaire Administration" (3 trials), "Recombinant Human Papillomavirus Bivalent Vaccine" (2 trials), "Biospecimen Collection" (1 trials), "Cytology Specimen Collection Procedure" (1 trials) and "Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed" (1 trials). Other intervention names were less common.

The vast majority of trials in "Agencia Costarricense de Investigaciones Biomédicas (ACIB)" are 4 trials for "Female" genders.

Currently, there are NaN active trials in "Agencia Costarricense de Investigaciones Biomédicas (ACIB)". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in Agencia Costarricense de Investigaciones Biomédicas (ACIB), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Agencia Costarricense de Investigaciones Biomédicas (ACIB), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".